Invesco Ltd. Provention Bio, Inc. Transaction History

Invesco Ltd.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$6.7 - $24.21 $3.31 Million - $12 Million	-493,716 Reduced 92.31%	41,150 $991,000
Q4 2022 Feb 13, 2023	BUY	$4.52 - $10.57 $2.3 Million - $5.37 Million	508,393 Added 1920.42%	534,866 $5.65 Million
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $10,475 - $17,163	3,054 Added 13.04%	26,473 $119,000
Q2 2022 Aug 15, 2022	SELL	$3.65 - $7.3 $742,004 - $1.48 Million	-203,289 Reduced 89.67%	23,419 $94,000
Q1 2022 May 16, 2022	BUY	$3.4 - $7.88 $698,577 - $1.62 Million	205,464 Added 967.16%	226,708 $1.66 Million
Q4 2021 Feb 14, 2022	SELL	$5.59 - $7.39 $19,084 - $25,229	-3,414 Reduced 13.85%	21,244 $120,000
Q3 2021 Nov 15, 2021	BUY	$5.66 - $8.33 $13,091 - $19,267	2,313 Added 10.35%	24,658 $157,000
Q2 2021 Aug 17, 2021	BUY	$6.71 - $11.04 $52,129 - $85,769	7,769 Added 53.3%	22,345 $189,000
Q1 2021 May 17, 2021	SELL	$10.12 - $19.45 $3.31 Million - $6.36 Million	-327,247 Reduced 95.74%	14,576 $153,000
Q4 2020 Feb 16, 2021	SELL	$11.79 - $18.94 $246,175 - $395,467	-20,880 Reduced 5.76%	341,823 $5.79 Million
Q3 2020 Nov 16, 2020	SELL	$10.34 - $15.2 $609,191 - $895,523	-58,916 Reduced 13.97%	362,703 $4.65 Million
Q2 2020 Aug 14, 2020	SELL	$7.81 - $17.0 $670,613 - $1.46 Million	-85,866 Reduced 16.92%	421,619 $5.95 Million
Q1 2020 May 15, 2020	BUY	$5.42 - $17.75 $1.92 Million - $6.29 Million	354,523 Added 231.77%	507,485 $4.67 Million
Q4 2019 Feb 14, 2020	BUY	$5.84 - $14.9 $893,298 - $2.28 Million	152,962 New	152,962 $2.28 Million

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.